Imatinib is a tyrosine kinase inhibitor used to treat cancers like chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting the BCR-ABL fusion protein and c-KIT, which are involved in the growth and spread of cancer cells. It is an oral medication that has revolutionized the treatment of certain cancers with genetic mutations.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Imatinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Imatinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Imatinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
